Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-36.21%
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-36.21%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
Immix Biopharma Inc fundamental performance
Across Immix Biopharma Inc's full reported history, from 2021 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 24M to -$ 29M. Revenue increased in 25% of the years measured; net income in 25%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-13 | $ 10.92 | — |
1 Year2025-08-13 | $ 2.33 | 368.67% |
All Time2021-12-16 | $ 3.67 | 197.55% |
| Period | Last Price2026-08-13 | 1 Year2025-08-13 | All Time2021-12-16 |
|---|---|---|---|
| Price | $ 10.92 | $ 2.33 | $ 3.67 |
| Return | — | 368.67% | 197.55% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 0.00 | -$ 29M | $ 100M |
| 2024 | $ 0.00 | -$ 21M | $ 17M |
| 2023 | $ 0.00 | -$ 15M | $ 17M |
| 2022 | -$ 89M | -$ 8M | $ 13M |
| IPO2021 | $ 0.00 | -$ 24M | $ 17M |
Explore beyond IMMX
You're looking at Immix Biopharma Inc. Members apply the same fundamental framework across all 3,859 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,859 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
